Lung cancer in never smokers: molecular profiles and therapeutic implications. - Wikidata - wikimedia - TriplyDB

Lung cancer in never smokers: molecular profiles and therapeutic implications.

Lung cancer in never smokers: molecular profiles and therapeutic implications.

http://www.wikidata.org/entity/Q34177155

about

Lung cancer in never smokers: clinical epidemiology and environmental risk factors Molecular biology of lung cancer: clinical implications Lung cancer: epidemiology, etiology, and prevention XPC mRNA level may predict relapse in never-smokers with non-small cell lung cancers Genomic aberrations in lung adenocarcinoma in never smokers Pathogenic mechanisms of lung adenocarcinoma in smokers and non-smokers determined by gene expression interrogation Chapter 6: Lung cancer in never smokers: epidemiology and risk prediction models The performance of NLST screening criteria in Asian lung cancer patients Pulmonary adenocarcinoma: a renewed entity in 2011 Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia Spectrum of LKB1, EGFR, and KRAS mutations in chinese lung adenocarcinomas.DOTS-Finder: a comprehensive tool for assessing driver genes in cancer genomes.Lung adenocarcinoma of never smokers and smokers harbor differential regions of genetic alteration and exhibit different levels of genomic instability.Biomass fuels and lung cancer.Field cancerization in non-small cell lung cancer: implications in disease pathogenesis.Relation between smoking history and gene expression profiles in lung adenocarcinomas Current concepts on the molecular pathology of non-small cell lung carcinoma.The potential role of lung microbiota in lung cancer attributed to household coal burning exposures.The A/G allele of rs16906252 predicts for MGMT methylation and is selectively silenced in premalignant lesions from smokers and in lung adenocarcinomas.Network-based differential gene expression analysis suggests cell cycle related genes regulated by E2F1 underlie the molecular difference between smoker and non-smoker lung adenocarcinoma.RARβ2 hypermethylation is associated with poor recurrence-free survival in never-smokers with adenocarcinoma of the lung Association of TERT Polymorphisms with Clinical Outcome of Non-Small Cell Lung Cancer Patients.Mitochondrial DNA mutations in respiratory complex-I in never-smoker lung cancer patients contribute to lung cancer progression and associated with EGFR gene mutation.Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking-related lung cancer Identification of Genetic Mutations in Human Lung Cancer by Targeted Sequencing.Differential efficacy of docetaxel according to non-small cell lung cancer histology and the therapeutic effect of epidermal growth factor receptor tyrosine kinase inhibitors Timeliness of Diagnosing Lung Cancer: Number of Procedures and Time Needed to Establish Diagnosis: Being Right the First Time.Genetic and biochemical alterations in non-small cell lung cancer.Quantified smoking status and non-small cell lung cancer stage at presentation: analysis of a North Indian cohort and a systematic review of literature.Association between the COMT 158 G/A polymorphism and lung cancer risk: a meta-analysis.Predictors of lung cancer: noteworthy cell type differences.Lung cancer in never smokers: a call to action.Tobacco Smoking and Lung Cancer: Perception-changing facts Differences in clinical presentation of non-small cell lung cancer in never-smokers versus smokers Impact of cigarette smoking on outcome of hepatocellular carcinoma after surgery in patients with hepatitis B Clinical impact of prevalence and severity of COPD on the decision-making process for therapeutic management of lung cancer patients The hypoxic tumor microenvironment: driving the tumorigenesis of non-small-cell lung cancer.Peculiar Genes Selection: A new features selection method to improve classification performances in imbalanced data sets Advances in EGFR as a Predictive Marker in Lung Adenocarcinoma.Racial and Ethnic Disparities in Early-Stage Lung Cancer Survival.

P2860

Q24598433-930E9DC7-235D-4338-80CC-20E45218AF47 Q24610335-B65F6791-06C8-42F7-925F-E1621612D50E Q24630167-86987CF0-B895-4950-A2EB-859322A8E50F Q28246216-08241190-34CE-4B8B-819B-C9FAAC87FEE5 Q28385032-166E3603-8E28-487D-8E83-A8A3423A5DE4 Q28385602-02E2F3E8-E5FA-449D-B3B2-42A5152B7D30 Q28390418-3ED9CF89-608D-47F1-BE24-3CF5E4508A23 Q28394235-79FCE134-099A-4970-A8FE-22639669C032 Q28395348-E02337A3-85A7-41BB-BF8E-BB3301DCD5C7 Q28943345-F9300DC2-0E3E-4800-9F9A-15C4AF135590 Q33563803-9B51D24F-992E-4344-9238-B96FF587575B Q33858472-5877550A-C0A0-41C5-80D6-602319165815 Q34193618-13F5AF88-3A69-4624-BE1E-3E2914B1B27F Q34225222-0F40F8A7-ED07-459E-A21C-E4C6917898D1 Q34272221-A20F578B-1AAF-4E9F-BE10-3543096374BD Q34296059-3C138EBC-8AC1-44BB-8BAF-48CAD861FE4E Q34310062-2F2B7D85-7E85-4E22-93C5-233C72E7E65E Q34440594-B1F60B39-CF44-4303-9A89-05D31C6242CA Q34762265-DA619767-5198-4579-8E86-4BEFD6E5F16F Q35068236-D416F2C2-79E7-4AB6-8734-D419112287FD Q35211946-DF7E4874-82FB-41B9-A961-C71B940B9360 Q35644577-E826A91E-F012-45FE-A7EF-19DAAFFDB45F Q35667130-DD55AB51-08CE-4A16-A49A-A68F970139F9 Q35788495-A1388346-1B33-4868-8B97-B573FBC92962 Q35811159-74B4091E-EF57-4FDA-BE77-4136B0FE215E Q36121683-2F7B562F-838F-4AE1-871E-FA7705D63E7E Q36153544-473AD9AF-FC7F-4122-A1DB-329D7DFE0D9C Q36184584-8E52FC9A-7865-48B1-AD87-956838ECA8F0 Q36287661-CF848C25-A6CF-43FA-86CC-9F237EAB76E1 Q36411618-56F592CE-8AF3-4CBC-8775-8C5A6108DD7A Q36869938-ED741950-E660-45EA-A30D-8ADBC4E45DBA Q37023811-B559FB55-6007-4070-A6FF-3CACA6590E0C Q37109569-7C10F31E-2E03-497D-BDD7-D3D9A9E27C94 Q37457385-81C53826-3C5C-4A92-BE44-21DF265C2E36 Q37483984-144E92EC-9F18-42B2-B1CD-058942A6070F Q37579720-59C8616E-A390-46E6-850E-8CD6535A3C84 Q38296670-1773D6B2-72BC-4127-8DCA-253D414702C7 Q38429904-9F5F95E2-CAF5-4B15-91E2-78DDAA2A9382 Q38526025-A7C4B94C-FC2C-4A21-BD91-843DB9688717 Q38816190-7C792FB2-302B-417E-953D-41EB53B7CDA2

P2860

Lung cancer in never smokers: molecular profiles and therapeutic implications.

http://www.wikidata.org/entity/Q34177155

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Lung cancer in never smokers: molecular profiles and therapeutic implications.

@ast

Lung cancer in never smokers: molecular profiles and therapeutic implications.

@en

Lung cancer in never smokers: molecular profiles and therapeutic implications.

@nl

type

label

Lung cancer in never smokers: molecular profiles and therapeutic implications.

@ast

Lung cancer in never smokers: molecular profiles and therapeutic implications.

@en

Lung cancer in never smokers: molecular profiles and therapeutic implications.

@nl

prefLabel

Lung cancer in never smokers: molecular profiles and therapeutic implications.

@ast

Lung cancer in never smokers: molecular profiles and therapeutic implications.

@en

Lung cancer in never smokers: molecular profiles and therapeutic implications.

@nl

P1433

Q34177155-EC3C15C4-AD3F-4198-BCB1-0134951D7DE6

P1476

Q34177155-4BC1D0E1-A3AD-4EF7-A120-2D328EE2B01A

P2093

Q34177155-00BFFA8C-754D-418D-8D9C-91D112E568DE

Q34177155-228AC7D7-D039-4695-87D6-2AEC9CE0E4A7

Q34177155-3462D294-3BA0-447F-A0FC-65D2249C2099

Q34177155-454BA828-29FE-40C6-93A2-E637B9E584E5

Q34177155-4E919343-A4CF-488F-B3CF-3E665E2F3C2B

Q34177155-61CC6FF4-42C7-4F82-8197-53409EE125F1

Q34177155-91A696C6-8D11-43B5-B1CE-0BADA1314671

Q34177155-D10F21F5-EF4F-43B5-A6D9-798A00593EFE

P2860

Q34177155-03069D53-5FD9-4624-99FD-5A17AACD8F6C

Q34177155-0336E94E-33A1-4A9B-B287-FF7123324425

Q34177155-0634286F-7A2D-4A0E-A4B9-49E4D6851643

Q34177155-0A6CD261-4A59-4AC3-91C6-10DA30AC5345

Q34177155-0AADD35C-E7A9-4539-AF20-7D0FD279846C

Q34177155-0CF6B06F-A5EC-48C5-A22A-7DE4495C1510

Q34177155-0EBBFD03-4395-4196-810E-87BA42BE1191

Q34177155-0F5194B6-2ED1-4BE2-A347-1680951B9BF0

Q34177155-100C14E4-7139-4A17-9A06-DBE7CA1E5692

Q34177155-18363FC7-78A7-4E14-8554-F5421526A820

P304

Q34177155-B5627375-4F71-4073-8216-5D9C997C1BC6

P31

Q34177155-F1AF8B64-A7A6-48DD-ADCE-77D391371838

P356

Q34177155-0C2FCC74-FCB6-48BB-9966-1074C0785D0C

P407

Q34177155-CE8FC0FF-A239-4B7A-B08F-EBE5C6F5C528

P433

Q34177155-6F75E55C-57EB-4D42-92B1-863D88419E11

P478

Q34177155-956B3307-FE6C-40BE-BE94-6A8A489F2B66

P50

Q34177155-20C39991-3480-4314-BFF2-809F9FEB61F0

P577

Q34177155-FD893EC3-8A41-49DB-B393-E98EBF997738

P5875

Q34177155-40E4C443-C0D6-48ED-8E85-077F0A38A0BA

P698

Q34177155-48E6DD00-0FB1-41B7-8C40-593554603B4A

P932

Q34177155-F62E5087-F30A-489C-9C35-B6A7741C896B

P356

1078-0432.CCR-09-0377

P1433

Clinical Cancer Research

P1476

Lung cancer in never smokers: molecular profiles and therapeutic implications.

@en

P2093

Ann G Schwartz

http://www.w3.org/2001/XMLSchema#string

Charles M Rudin

http://www.w3.org/2001/XMLSchema#string

Curtis C Harris

http://www.w3.org/2001/XMLSchema#string

Erika Avila-Tang

http://www.w3.org/2001/XMLSchema#string

Fred R Hirsch

http://www.w3.org/2001/XMLSchema#string

James G Herman

http://www.w3.org/2001/XMLSchema#string

Jonathan M Samet

http://www.w3.org/2001/XMLSchema#string

Kirsi H Vahakangas

http://www.w3.org/2001/XMLSchema#string

P2860

Familial risk of lung cancer among nonsmokers and their relatives

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

Lung cancer in never smokers: clinical epidemiology and environmental risk factors

Somatic mutations affect key pathways in lung adenocarcinoma

Characterizing the cancer genome in lung adenocarcinoma.

The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma.

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Surfing the p53 network

P304

5646-5661

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-09-0377

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26813235

http://www.w3.org/2001/XMLSchema#string

P698

19755392

http://www.w3.org/2001/XMLSchema#string

P932

2950319

http://www.w3.org/2001/XMLSchema#string